Zepbound Approval for Sleep Apnea: American Academy of Sleep Medicine Statement
December 24, 2024
December 24, 2024
DARIEN, Illinois, Dec. 24 -- The American Academy of Sleep Medicine issued the following news release:
On Dec. 20, Eli Lilly announced the Food and Drug Administration has approved the injectable prescription medicine Zepbound (tirzepatide) for adults with moderate-to-severe obstructive sleep apnea and obesity. The American Academy of Sleep Medicine provides the following statement for patients and clinicians.
AASM statement on Zepbound approval
The FDA app . . .
On Dec. 20, Eli Lilly announced the Food and Drug Administration has approved the injectable prescription medicine Zepbound (tirzepatide) for adults with moderate-to-severe obstructive sleep apnea and obesity. The American Academy of Sleep Medicine provides the following statement for patients and clinicians.
AASM statement on Zepbound approval
The FDA app . . .